Financial Architects (New Jersey)’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-1,463
| Closed | -$7K | – | 1429 |
|
|
2019
Q1 | $7K | Hold |
1,463
| – | – | ﹤0.01% | 1061 |
|
|
2018
Q4 | $3K | Hold |
1,463
| – | – | ﹤0.01% | 1097 |
|
|
2018
Q3 | $9K | Hold |
1,463
| – | – | ﹤0.01% | 1009 |
|
|
2018
Q2 | $10K | Hold |
1,463
| – | – | ﹤0.01% | 1004 |
|
|
2018
Q1 | $12K | Hold |
1,463
| – | – | ﹤0.01% | 912 |
|
|
2017
Q4 | $14K | Hold |
1,463
| – | – | ﹤0.01% | 938 |
|
|
2017
Q3 | $17K | Buy |
1,463
+1,088
| +290% | +$12.6K | ﹤0.01% | 912 |
|
|
2017
Q2 | $16K | Hold |
375
| – | – | ﹤0.01% | 925 |
|
|
2017
Q1 | $18K | Hold |
375
| – | – | ﹤0.01% | 874 |
|
|
2016
Q4 | $12K | Hold |
375
| – | – | ﹤0.01% | 960 |
|
|
2016
Q3 | $15K | Hold |
375
| – | – | ﹤0.01% | 904 |
|
|
2016
Q2 | $12K | Buy |
+375
| New | +$12K | ﹤0.01% | 924 |
|